Todd Foley, Director at Repare Therapeutics Inc. (RPTX), sold 34,425 shares at $33.78 ($1.2M) on 2021-06-17, disclosed to the SEC on 2021-06-21.
Open-market sale of $1.2M RPTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.78 | 13,575 | $459K | 39.5% |
| 2 | $33.78 | 13,575 | $459K | 39.5% |
| 3 | $34.12 | 753 | $26K | 2.2% |
| 4 | $33.46 | 2,556 | $86K | 7.4% |
| 5 | $33.46 | 2,556 | $86K | 7.4% |
| 6 | $34.03 | 1,410 |
| $48K |
| 4.1% |
| Total | $33.75 avg | 34,425 | $1.2M | 100% |
| Filing → |
| ITOS | SELL | 2021-10-12 | $2.8M | — | Filing → |
| ITOS | SELL | 2021-09-20 | $5.2M | — | Filing → |
| RPTX | SELL | 2021-07-13 | $1.8M | — | Filing → |